AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,684 | -42.5% | 3,869 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $42,907 | -20.8% | 3,869 | +9.6% | 0.00% | -33.3% |
| Q1 2023 | $54,201 | -26.2% | 3,531 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $73,471 | +51.4% | 3,311 | +11.4% | 0.00% | +50.0% |
| Q3 2022 | $48,533 | +12.4% | 2,972 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $43,183 | +5.9% | 2,972 | +34.6% | 0.00% | +100.0% |
| Q1 2022 | $40,782 | -81.7% | 2,208 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $222,701 | -3.5% | 9,369 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $230,758 | -0.3% | 9,369 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $231,508 | +18.6% | 9,369 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $195,156 | +50.6% | 8,948 | +76.2% | 0.00% | +50.0% |
| Q4 2020 | $129,565 | -9.3% | 5,077 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $142,918 | – | 5,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |